(Q36053488)

11 August 2017

Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats (English)

1 reference

11 August 2017

G J Coope

1

1 reference

11 August 2017

A M Atkinson

2

1 reference

11 August 2017

C Allott

3

1 reference

11 August 2017

D McKerrecher

4

1 reference

11 August 2017

C Johnstone

5

1 reference

11 August 2017

K G Pike

6

1 reference

11 August 2017

P C Holme

7

1 reference

11 August 2017

H Vertigan

8

1 reference

11 August 2017

D Gill

9

1 reference

11 August 2017

M P Coghlan

10

1 reference

11 August 2017

B Leighton

11

1 reference

11 August 2017

language of work or name

English

0 references

publication date

21 August 2006

1 reference

British Journal of Pharmacology

11 August 2017

1 reference

11 August 2017

149

1 reference

11 August 2017

3

1 reference

11 August 2017

328-335

1 reference

Targeting glucokinase activation for the treatment of type 2 diabetes--a status review.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Glucokinase, glucose homeostasis, and diabetes mellitus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Small molecule glucokinase activators as novel anti-diabetic agents.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Current and emerging therapies for type 2 diabetes.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Metho

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Drug-protein binding sites. New trends in analytical and experimental methodology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Pancreatic islet glucose metabolism and regulation of insulin secretion

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Design of a potent, soluble glucokinase activator with excellent in vivo efficacy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

A novel glucokinase activator modulates pancreatic islet and hepatocyte function

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Discovery, synthesis and biological evaluation of novel glucokinase activators.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Allosteric activators of glucokinase: potential role in diabetes therapy

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical mode

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

Effects of clenbuterol on insulin resistance in conscious obese Zucker rats

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

A1 adenosine receptor antagonism improves glucose tolerance in Zucker rats.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014270

The postprandial rates of glycogen and lipid synthesis of lean and obese female Zucker rats

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16921397

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16921397

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJP.0706848

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

16921397

1 reference